MAVILIO, Fulvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.581
AS - Asia 7.395
EU - Europa 6.441
SA - Sud America 1.005
AF - Africa 120
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.410
SG - Singapore 3.409
GB - Regno Unito 2.072
CN - Cina 1.737
HK - Hong Kong 1.231
RU - Federazione Russa 972
IT - Italia 894
BR - Brasile 843
SE - Svezia 739
DE - Germania 485
VN - Vietnam 303
FI - Finlandia 297
UA - Ucraina 246
BG - Bulgaria 215
TR - Turchia 190
FR - Francia 176
ID - Indonesia 106
KR - Corea 92
CA - Canada 77
JP - Giappone 70
AR - Argentina 67
IN - India 65
IE - Irlanda 56
NL - Olanda 53
MX - Messico 46
BE - Belgio 44
BD - Bangladesh 37
ZA - Sudafrica 32
PL - Polonia 30
AU - Australia 28
EC - Ecuador 26
AT - Austria 24
EG - Egitto 23
IQ - Iraq 23
ES - Italia 22
MA - Marocco 20
CO - Colombia 19
UZ - Uzbekistan 19
AE - Emirati Arabi Uniti 17
BZ - Belize 17
LT - Lituania 17
SI - Slovenia 15
CL - Cile 14
VE - Venezuela 14
IR - Iran 13
CH - Svizzera 11
TN - Tunisia 11
LU - Lussemburgo 10
PK - Pakistan 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
KE - Kenya 9
PH - Filippine 9
GR - Grecia 8
RO - Romania 8
CR - Costa Rica 7
PE - Perù 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
MY - Malesia 6
PA - Panama 6
PY - Paraguay 6
SA - Arabia Saudita 6
TW - Taiwan 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
NG - Nigeria 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
JO - Giordania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GH - Ghana 3
KG - Kirghizistan 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 31.562
Salva come PNG Salva come JPEG
Città #
Singapore 2.601
Fairfield 2.044
Santa Clara 1.860
Ashburn 1.326
Hong Kong 1.225
Southend 1.212
Woodbridge 1.088
Chandler 951
Houston 934
Wilmington 667
Seattle 657
Cambridge 623
Ann Arbor 596
London 548
Jacksonville 501
Nyköping 455
Hefei 402
Dearborn 386
Beijing 367
Los Angeles 279
Chicago 277
San Diego 262
Modena 240
Princeton 219
Sofia 213
Helsinki 210
The Dalles 156
Salt Lake City 120
Bremen 119
New York 119
Buffalo 115
Eugene 102
Jakarta 88
Seoul 88
Shanghai 88
Ho Chi Minh City 87
Moscow 83
Council Bluffs 74
Izmir 73
Elk Grove Village 68
São Paulo 65
Des Moines 62
Milan 62
Dublin 56
Hanoi 56
Dong Ket 52
Tampa 51
Dallas 48
San Jose 44
Brussels 43
Redwood City 38
Redondo Beach 37
San Francisco 36
Norwalk 35
Columbus 34
Frankfurt am Main 32
Tokyo 31
Boardman 30
Rio de Janeiro 30
Belo Horizonte 29
Bonndorf 29
Lancaster 28
Falls Church 27
Hounslow 26
Munich 26
Rome 26
Brooklyn 25
Guangzhou 24
Toronto 24
Atlanta 23
Nuremberg 23
Paris 23
Sterling 23
Kilburn 22
Phoenix 22
Warsaw 21
Montreal 18
Nanjing 18
Belize City 17
Cairo 17
Hangzhou 17
Melbourne 17
Mexico City 17
Brasília 16
Dulles 16
Kent 16
Kocaeli 16
Tashkent 16
Wuhan 15
Boston 14
Camden 14
Charlotte 13
Dhaka 13
Haiphong 13
Istanbul 13
Pittsburgh 13
Prescot 13
Trieste 13
Boydton 12
Da Nang 12
Totale 23.145
Salva come PNG Salva come JPEG
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 864
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 366
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 365
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 361
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 355
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 332
Comprehensive genomic access to vector integration in clinical gene therapy 320
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 310
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 301
Site-specific integration by the adeno-associated virus rep protein 299
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 294
Mechanisms of retroviral integration and mutagenesis 294
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 293
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 288
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 283
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 281
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 279
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 272
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 268
Medicina rigenerativa e nuove frontiere terapeutiche 267
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 264
A single epidermal stem cell strategy for safe ex vivo gene therapy 264
Nuclear architecture dictates HIV-1 integration site selection 263
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 259
Site-specific integration into the human genome: Ready for clinical application? 258
Gene therapy approaches for epidermolysis bullosa 255
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 255
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 253
Tracking gene-modified T cells in vivo. 252
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 251
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 248
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 247
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 245
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 245
Gene therapy of skin adhesion disorders (mini review) 244
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 240
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 238
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 235
Muscle-derived hematopoietic stem cells are hematopoietic in origin 232
Stem cell plasticity: time for a reappraisal? 231
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 230
Defining the lentiviral integrome in human hematopoietic cells 229
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 227
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 225
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 224
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 224
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 222
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 221
Gene therapy of inherited skin adhesion disorders: a critical overview 219
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 217
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 217
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 217
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 216
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 215
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 214
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 212
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 208
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 208
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 208
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 206
Towards a gene therapy clinical trial for epidermolysis bullosa 203
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 202
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 197
Clonal analysis of stably transduced human epidermal stem cells in culture. 196
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 196
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 195
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 195
Interactions between Retroviruses and the Host Cell Genome 194
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 193
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 192
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 190
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 187
Toward gene therapy of junctional epidermolysis bullosa (JEB) 186
Safety of retroviral gene marking with a truncated NGF receptor 183
Gene therapies need new development models 182
Repairing without cutting: A safer alternative to gene correction? 181
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 179
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 178
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 177
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 175
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 173
Perspectives on Best Practices for Gene Therapy Programs 172
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 172
The future of gene therapy 168
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 167
Epithelial stem cells in corneal regeneration and epidermal gene therapy 165
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 163
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 163
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 159
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 158
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 155
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 153
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 151
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 151
Gene therapy: back on track? 145
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy 144
A human homoeo box gene specifically expressed in spinal cord during embryonic development 143
Alternative splicing caused by lentiviral integration in the human genome 140
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene 139
Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency 137
Totale 22.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.157 0 0 0 0 0 317 215 342 322 439 314 208
2021/20223.677 389 358 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20256.512 187 55 68 494 1.324 934 338 365 789 471 710 777
2025/20266.449 701 445 866 1.380 2.794 263 0 0 0 0 0 0
Totale 31.914